Abingdon Health PLC - York, England-based lateral flow test contract development and manufacturing company - Ahead of its annual general meeting on Friday morning, says revenue for the six months to December 31 will be ‘significantly higher’ than £1.1 million a year ago. Adds that it remains ‘hugely focused’ on continuing to grow revenue and reduce its cash-burn throughout the year ending June 30.

Current stock price: 9.00 pence, up 2.9%

12-month change: more than doubled from 4.00p

Copyright 2023 Alliance News Ltd. All Rights Reserved.